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ABSTRACT
Co-crystal is a mixed crystal or crystal that contains two or more different
molecules. In this study, the solid phase transformation of CBZ-AA co-crystal and
solubility of carbamazepine (CBZ) and adipic acid (AA) is examined. In this dissertation,
the solubility of CBZ and AA via HPLC and gravimetric methods are reported. On the
other hand, the study of solid phase transformation is planned to proceed via slurry co-
crystallization method. The result shows the solubility of CBZ and AA via gravimetric and
HPLC method is increased as the temperature increased from 25 ˚C to 50 ˚C. TGA analysis
shows the weight changed of CBZ is 96.21 % at decomposed temperature of 250 ˚C and
94.47 % for AA at 220 ˚C decomposed temperature.  The wavenumbers corresponding to
CBZ and AA is obtained from FTIR analysis. Due to time limitation, the phase
transformation of CBZ-AA co-crystal is suggested to be continued by another student in the
future.
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ABSTRAK
Ko-kristal adalah kristal yang bercampur atau kristal yang mengandungi dua atau
lebih molekul yang berbeza. Dalam kajian ini, transformasi fasa pepejal CBZ-AA bersama
kristal dan keterlarutan carbamazepine (CBZ) dan asid adipic (AA) diperiksa. Dalam
disertasi ini, keterlarutan CBZ dan AA melalui kaedah HPLC dan gravimetrik dilaporkan.
Sebaliknya, kajian transformasi fasa pepejal merancang untuk meneruskan melalui kaedah
buburan bersama-penghabluran. Hasilnya menunjukkan keterlarutan CBZ dan AA melalui
gravimatrik dan kaedah HPLC meningkat apabila suhu meningkat daripada 25 ˚ C hingga
50 ˚ C. Analisis TGA menunjukkan berat yang berubah daripada CBZ adalah 96,21% pada
suhu lebur sebanyak 250 ˚ C dan 94,47% untuk AA pada suhu 220 ˚ C. Wavenumbers
sepadan CBZ dan AA diperolehi daripada analisis FTIR. Oleh kerana had masa,
transformasi fasa CBZ-AA ko-kristal dicadangkan untuk diteruskan oleh pelajar lain pada
masa akan datang.
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1CHAPTER 1
INTRODUCTION
1.0 Research background
Co-crystals have recently gained attention as attractive alternate solid forms for
drug development. A pharmaceutical co-crystal is a single crystalline homogenous
phase consisting of a drug and excipient or another drug. (Trask et al., 2005; Etter et al.,
1990; Pedireddi et al., 1996; Trask et al., 2004; Morissette et al., 2004; Nehm et al.,
2005; Rodriguez et al., 2006; Crowley et al., 2002).The different components in the co-
crystal are neutral in nature when compared to salts that have ionized components.
(Etter et. al., 1990; Morissette et al., 2004).
Co-crystals, multiple component crystals, often rely on hydrogen-bonded
assemblies between neutral molecules of the active pharmaceutical ingredient (API) and
other components with well-defined stoichiometries (Etter 1991; Caira 1992; Desiraju
1995; Nangia and Desiraju 1998; Byrn, Pfeiffer et al. 1999; Aakeroy, Beatty et al. 2002;
Almarsson and Zaworotko 2004; Wenger and Bernstein 2008). Therefore, co-crystals
increase the diversity of solid-state forms of an API even for non-ionizable APIs, and
enhance pharmaceutical properties by modification of chemical stability, moisture
2uptake, mechanical behavior, solubility, dissolution rate, and bioavailability (Remenar,
Morissette et al. 2003; Rodríguez-Spong, Zocharski et al. 2003; Childs, Chyall et. al.,
2004; Rodríguez-Spong, Price et. al. 2004; Zocharski, Nehm et. al. 2004; Rodríguez-
Spong 2005; Trask, Motherwell et al. 2005; Nehm, Rodríguez-Spong et. al. 2006).
Families of API co-crystals are being designed and prepared by applying
molecular recognition, thermodynamic, and kinetic principles to build hydrogen-bonded
molecular assembly of multiple components. Co-crystals are gaining much interest
because the resulting new crystal forms of APIs have different physical and chemical
properties compared to the original API.
1.1 Co-crystal
In 1984, Kitaigorodski defined co-crystal as “a mixed crystal or crystal that
contains two differents molecules”. An alternatives approach that arises conceptually
from applying the concepts of supra-molecular chemistry and crystal engineering is that
a co-crystal is the consequence of a molecular recognition event between molecular
species. (Dunitz and Desiraju, 2003).
Co-crystal incorporates pharmaceutically acceptable guest molecules into a
crystal lattice along with the API. Co-crystals are homogeneous solid phases containing
two or more neutral molecular components in a crystal lattice with defined
stoichiometry, which are solids at room temperature and are held together by weak
interactions, mainly hydrogen bonding (Aakeroy and Salmon, 2005). Co-crystal has
regained attention as attractive alternate solid forms for drug development.
Physiochemical properties of pharmaceuticals can be improved by obtaining co-crystal
3using co-crystallization (Shan and Zaworotko, 2008; Jones et al., 2006). In their pure
states generally co-crystal are solids at room temperature and by convention, normally
these also excludes salts. Co-crystal can have different properties, crystal structures,
different intermolecular packing patterns, and often exhibit widely different physical
properties than their pure components. (Miroshnyk et al., 2009; McMahon, 2006).
1.2 Objective
Based on research background mentioned above, the objectives of this study are:
- To measure the solubility of CBZ and AA.
- To study the phase transformation of CBZ-AA co-crystal formation.
1.3 Scope of research
The scopes of research are listed as below:
 Measure solubility of CBZ and AA via gravimetric and HPLC method.
 Manipulate the AA to CBZ ratio to measure co-crystal transformation based on
solubility data obtained.
41.4 Significance of research
This study were carried out to measure the solubility of CBZ and AA, later to be
used to manipulate the AA to CBZ ratio in order to study the co-crystal transformation
region. The transformation study is important because we can determine the suitable
concentration range of CBZ and AA to produce co-crystal.
1.5 Report layout
This report contains five main chapters to distribute the whole report
accordingly. In the first chapter, explained the introduction which gave the briefing
about the project. The second chapter contains literature review based on crystallization
and co-crystal. The third chapter explained the methodologies of the experiment and
fourth chapter contained results and discussions. Finally, fifth chapter contains with
conclusions and recommendations.
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LITERATURE REVIEW
2.1 Introduction
2.1.1 Crystallization
Crystallization is a process where solid particles are formed from homogeneous
phase. Crystallization process can occur in the freezing of water to form ice, in the
formation of snow particles form a vapor, in the formation of solid particles from a
liquid melt, or in the formation of solid crystals from a liquid solution (Geankoplis,
2003).  From the last process that mentioned above, crystallization from a solution is the
most important one commercially. In crystallization the solution is concentrated and
usually cooled until the solute concentration becomes greater than its solubility at that
temperature. Then the solute comes out of the solution, forming crystals of
approximately pure solute (Geankoplis, 2003).
8There are seven classes of crystal that can be classified, depending upon the
arrangement of the axes to which the angles are referred:
1) Cubic system. Three equals axes at right angles to each other.
2) Tetragonal system. Three axes at right angles to each other, one axis longer than
the other two.
3) Orthorhombic system. Three axes at right angles to each other, all of different
length.
4) Hexagonal system. Three equal axes in one plane at 60° to each other, and fourth
axis at right angle to this plane and not necessarily at the same length.
5) Monoclinic system. Three unequal axes, two at right angles in plane and a third
at some angle to this plane.
6) Triclinic system. Three unequal axes at unequal angles to each other and not 30,
60, or 90.
7) Trigonal system. Three equal and equally inclined axes.
2.1.2 Co-crystallization
Co-crystallization is a result of competing molecular associations between
similar molecules, or homomers, and different molecules or heteromers. Hydrogen
bonds are the basis of molecular recognition phenomena in pharmaceutical systems and
are responsible for the generation of families of molecular networks with the same
molecular components (single component crystals and their polymorphs) or with
different molecular components (multiple component crystals or co-crystals) in the
crystalline state (Jayasankar et al., 2006)
92.1.3 Physical properties of co-crystals
As there is no new covalent bond formed in a co-crystal compared to its mother
molecules, the chemical properties of the original compounds will be well preserved.
However, the crystal structure of a co-crystal is totally different from the crystals of its
mother compounds. Therefore a co-crystal has different physical properties from its
mother crystals (as shown in Figure 2.1).
(a) (b)
Figure 2.1: (a) CBZ-saccharin co-crystal, (b) CBZ-nicotinamide co-crystal. (Zaworotko,
2003 and Rodriguez-Hornedo et al., 2003).
2.2 Crystallization process
The crystallization process consists of two major events, nucleation and crystal
growth. Nucleation is the step where the solute molecules dispersed in the solvent start
to gather into clusters, on the nanometer scale (elevating solute concentration in a small
region), that become stable under the current operating conditions. The crystal growth is
the subsequent growth of the nuclei that succeed in achieving the critical cluster size.
Nucleation and growth continue to occur simultaneously while the supersaturation
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exists. Supersaturation is the driving force of the crystallization; hence the rate of
nucleation and growth is driven by the existing supersaturation in the solution.
2.2.1 Solubility
Solubility studies were conducted by equilibrating excess solids in appropriate
solvent mixtures for a minimum of 3d. A single HPLC method using YMC-ODS-AM
column was developed and run on an Agilent 1100 system to quantify both CBZ and
AA concentrations. Solubility data obtained from the HPLC method were compared and
shown to be similar to the data obtained from the gravimetric analysis of the solubility
samples.
2.2.2 Nucleation
Nucleation is a physical reaction which occurs when components in a solution
start to precipitate out, forming nuclei which attract more precipitate. This physical
reaction is the basis for a variety of manufacturing processes and interesting natural
phenomena.
Nucleation can often be induced by agitation, mechanical shock, friction and
extreme pressure within solutions and melts. (Young, 1911 and Berkeley, 1912). The
erratic effects of external influences such as electric and magnetic field, spark
discharges, ultra-violet light, X-ray, sonic and ultrasonic irradiation have also been
studied over many years (Khamskii, 1969) but so far none of this methods has found
any significant application in large-scale crystallization process.
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There have two behavior term will be defined in nucleation that it primary and
secondary. Primary term is for all cases of nucleation in systems that do not contain
crystalline matter. In primary, the cases is divide into two part that called homogeneous
(spontaneous) and heterogeneous (induced by foreign particle). On the other hand,
nuclei are often induced by crystals present in a supersaturated system; this behavior is
been called secondary.
2.2.3 Crystal growth
As soon as stable nuclei have been formed in a supersaturated or super cooled
system, they begin to grow into crystals of visible size. There have been many proposed
for mechanisms of crystal growth such as surface energy theories, diffusion theories,
adsorption layer theories, and kinematic theories.
The surface energy theories are based on the postulation that the shape a growing
crystal assumes is that which has a minimum surface energy. In 1878 Gibbs (1948)
suggested that the growth of a crystal could be considered as a special case of this
principle; the total free energy of a crystal in equilibrium with its surroundings at a
constant temperature and pressure would be minimum for a given volume.
The diffusion theories presume that the matter is deposited continuously on a
crystal face at a rate proportional to the difference in concentration between the point of
deposition and the bulk of the solution. The origin of the diffusion theories dates back to
the work of (Noyes and Whitney, 1897) who considered that the deposition of solid on
the face of a growing crystal was essentially a diffusion process. They also assumed that
crystallization was the reverse of dissolution and that the rates of both processes were
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governed by the difference between concentration at the solid surface and in bulk of the
solution.
The adsorption layer theories define that concept of a crystal growth mechanism
base on the existence of an adsorbed layer of solute atoms or molecules on a crystal face
(Volmer, 1939).
Kinematic theories is about two processes involved in the layer growth of
crystals, the generation of steps at some source on the crystal face followed by the
movement of layers across the face. Consideration of the movement of macro steps of
unequal distance apart (BCF theory considers a regular distribution of monatomic steps)
to develop a ‘kinematic’ theory of crystal growth (Frank, 1958).
2.3 Development of co-crystal
2.3.1 Co-crystal screening method
Co-crystal screening methodology has advanced from being empirically based to
a more efficient and rational basis (Childs et al., 2008). The method can be broadly
being categorized as solid-based and liquid based (Table 2.1). While solid-based
methods often rely on the stoichiometric ratio of the reactants for co-crystal formation,
the liquid-based methods can be either stoichiometric such as (slow evaporative
crystallization, spray drying) or non-stoichiometric such as (slurry and reaction
crystallization) (Alhalaweh and Velaga, 2010; Rodriguez-Hornedo et al., 2006; Zhang et
al., 2007).
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Table 2.1: Shows the liquid-based method and solid-based method
Liquid-based methods Solid-based methods
Slow evaporation
Slurry conversion
Reaction co-crystallization
Cooling crystallization
Liquid-assisted grinding
Supercritical fluids
Spray drying
Melt crystallization
Solid-state grinding
Melt extrusion
2.3.2. Co-crystallization techniques
2.3.2.1 Slow evaporation.
This technique is the simplest way to grow crystals and works best for
compounds which are not sensitive to ambient conditions in the laboratory. The solution
of the compound is been prepared in a suitable solvent until the solution is saturated or
nearly saturated. After that, the solution is transferred to a clean crystal growing dish
and cover. The covering for the container should not be air tight. Aluminium foil with
some holes poked in it works well, or a flat piece of glass with microscope slides used
as a spacer also will do the trick. The container is placed in a quiet out of the way place
and let it evaporate. This method works best where there is enough material to saturate
at least a few milliliters of solvent (Jones, 1981).
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2.3.2.2 Slow cooling.
A saturated solution of the compound is prepared where is the solvent is heated to
just its boiling point or a just below it. Transferred the solution to a clean large test tube
and placed it into Dewar flask in which hot water (heated to a temperature of a couple of
degrees below the solvent boiling point (<100˚C)). The water level should exceed the
solvent level in the test tube. Stopper the Dewar flask with a cork stopper and let the
vessel sit for a week. A more elaborate version of this involves a thermo stated oven
rather than a Dewar flask (Jones, 1981).
2.3.2.3 Slurry.
API component or co-former solid it’s been dissolved into ethanol solvent till
equilibrium of those mixed is achieved. Then, solution is left for 3 days (72 hours) with
stirring. After 3 days, the exceed solution is filtrate by using syringe, syringe filter and
needle into volumetric flask. The filter solution is around 4 ml. 1ml from it is dilute to
test it solubility in High Performance Liquid Chromatography (HPLC) and another 3ml
from it using in gravimetric solubility test. (Takata et al., 2008)
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2.3.2.4 Grinding.
When preparing co-crystals, the product obtained from grinding is generally
consistent with that obtained from solution. This may indicate that hydrogen-bond
connectivity patterns are not idiosyncratic or determined by non-specific and
unmanageable solvent effects or crystallization conditions. Nevertheless there are
exceptions. Whilst many co-crystal materials can be prepared from both solution growth
and solid-state grinding, some can only be obtained by solid-state grinding. Failure to
form co-crystals by grinding may be due to an inability to generate suitable co-crystal
arrangements rather than due to the stability of the initial phases (Blagden et al., 2007).
Solid state grinding is not a new method for co-crystal formation – it was first
reported in the late 19th century. By this method, co-crystals were prepared by co-
grinding two parent compounds together by machine or by hand. Many co-crystal
materials could be prepared by both solid state grinding and solution growth. In some
report recently, solid state grinding is used to reduce the experiment burden of co-crystal
screening (Friscic, 2006). Moreover, it could also be used to prepare novel
pharmaceutical co-crystal materials which are not readily accessible by solution growth.
Successful examples of co-crystals prepared by this method include the co-crystal of
caffeine with monocarboxylic acids (Rodríguez-Hornedo, Nehm.2006), and the co-
crystal by carboxamide-pyridine N-oxide heterosynthon (Reddy. 2006).
The other technique than that has been state above that can be used for co-crystallization
is reaction co-crystallization and melt.
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2.4 Solubility analysis method
Solubility analysis of sample can be done by using gravimetric analysis method
and by using high performance liquid chromatography (HPLC) analysis. This is to
compare to the different value of solubility of the sample between the two methods. In
this research, just CBZ is been analyze by using HPLC.
2.4.1 High performance liquid chromatography (HPLC)
HPLC (as shown in Figure 2.2) is a technique most commonly used for the
quantitation of drugs in pharmaceutical formulations. HPLC involves the simultaneous
separation and quantitation of compounds in a sample matrix that has been introduced
onto a chromatographic column, packed with a stationary phase. Separation is achieved
by the use of a stationary phase and a solvent, termed the mobile phase, that is allowed
to flow through the stationary phase at a set flow rate, for isocratic chromatography
(Dumortier et al., 2001 and Meyer et al., 2002).
During analysis, the sample components partition to differing degrees between a
stationary and mobile phase, based on their inherent physico-chemical properties
(Meyer et al., 2002). The nature of the physico-chemical interaction between the mobile
and stationary phase allows solute molecules to emerge from the column in individual
component zones or bands, which are then monitored as a function of an appropriate
detector response versus time.
